Home / Conferences

Conferences

Medicines for Europe 3rd Value Added Medicines Conference 2019

3rd Value Added Medicines Conference
21 November 2019
Renaissance Hotel, Brussels
Belgium

Medicines for Europe 13th Pharmacovigilance Conference 2020

13th Pharmacovigilance Conference 2020
29 January 2020
Hilton Hotel, Apollolaan, Amsterdam
The Netherlands

Medicines for Europe 19th Regulatory and Scientific Affairs Conference 2020

19th Regulatory and Scientific Affairs Conference 2020
30–31 January 2020
Hilton Hotel, Apollolaan, Amsterdam
The Netherlands

Terrapinn Festival of Biologics USA 2020

The Festival of Biologics San Diego 2020
2‒4 March 2020 
Loews Resort Colonardo, San Diego
USA

Medicines for Europe 18th Biosimilar Medicines Conference 2020; ‘Biosimilars: Reshaping the Access Landscape‘

18th Biosimilar Medicines Conference 2020; ‘Biosimilars: Reshaping the Access Landscape’
26‒27 March 2020
Hilton Hotel, Apollolaan, Amsterdam
The Netherlands

Medicines for Europe 16th Legal Affairs Conference 2020

16th Legal Affairs Conference 2020
1–2 April 2020
the Tower Hotel, London
UK

Microbiological control symposium: consensus on readiness of new methods emerges

A symposium on microbiology in the pharmaceutical sector was the opportunity for the European Directorate for the Quality of Medicines & HealthCare (EDQM) to gather feedback from users of the European Pharmacopoeia on alternative testing methods for microbiological control and sterilisation processes. The event, which took place in Strasbourg on 10−11 October 2017, was attended by a wide range of experts in the pharmaceutical and microbiological fields who reviewed the latest trends and innovations in the field of microbiology, in addition to pharmacopoeial approaches and related regulatory requirements.

European Pharmacopoeia prepares for the future through exchange with stakeholders

To mark the publication of the 9th edition of the European Pharmacopoeia (Ph. Eur.), the EDQM (European Directorate for the Quality of Medicines) organized a large international conference in Tallinn, Estonia, which brought together representatives of European and international regulatory authorities, the World Health Organization (WHO), pharmacopoeias from different continents as well as industry and associations from Europe and beyond. Participants came from 41 different countries, including Brazil, Canada, India, Japan, South Africa, Taiwan and USA.

French generics association promotes biosimilars

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Topics presented at the 16th IGPA conference on generics

Topics presented at the 16th Annual IGPA Conference, held in Brussels, Belgium, 9–11 December 2013, showed that despite differences in the pharmaceutical market in different countries most appreciate the value of generics. In most cases this is driven by cost reduction.